Article info
PDFAuthor meets critics: Response
Reasons, causes and identity
- Correspondence to Dr Andrew McGee, Australian Centre for Health Law Research, Faculty of Law, Queensland University of Technology, Brisbane, QLD 4001, Australia; a.mcgee{at}qut.edu.au
Citation
Reasons, causes and identity
Publication history
- Received October 10, 2017
- Accepted October 16, 2017
- First published November 16, 2017.
Online issue publication
December 18, 2017
Article Versions
- Previous version (16 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Identity, Personhood and the Law: Charles Foster and Jonathan Herring. Springer, 2017: ISBN 978-3-319-53458-9: 70 pp.
- Stimulating brains, altering minds
- Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease
- Ethical examination of deep brain stimulation’s ‘last resort’ status
- Withdrawing clinically assisted nutrition and hydration (CANH) in patients with prolonged disorders of consciousness: is there still a role for the courts?
- Views of the person with dementia
- The burden of normality: from ‘chronically ill’ to ‘symptom free’. New ethical challenges for deep brain stimulation postoperative treatment
- Withering Minds: towards a unified embodied mind theory of personal identity for understanding dementia
- Informed consent for clinical trials of deep brain stimulation in psychiatric disease: challenges and implications for trial design
- Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a ‘new form of the disease’